Stock listing
B3:T1EV34 Teva Pharmaceutical Industries Limited Ações
Brazilian listing (B3) of Teva Pharmaceutical Industries Limited · home listing TASE:TEVA
Follow Teva Pharmaceutical Industries Limited into a list and get an email when it puts out news.
Share price · BMFBOVESPA:T1EV34
104.72 BRL -0.08 (-0.1%)
Close on Oct 19, 2026
- Day range
- 102.70 – 104.72 BRLOct 19, 2026
- Volume
- 11 sharesOct 19, 2026
- Market cap
- 244.3B BRLAt the close on Oct 19, 2026 · price × 2.33B shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| TASE:TEVA · Home | 12,850 ILA (agorot) | -80 (-0.6%) | 977,554 | 12,890 | 13,070 | 12,760 | 12,930 | Close on Oct 20, 2026 |
| NYSE:TEVA | $41.31 USD | -0.19 (-0.5%) | 3,827,812 | $41.42 | $41.88 | $41.25 | $41.50 | Close on Oct 19, 2026 |
| B3:T1EV34 | 104.72 BRL | -0.08 (-0.1%) | 11 | 102.70 | 104.72 | 102.70 | 104.80 | Close on Oct 19, 2026 |
- Ticker
- B3:T1EV34
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- B3
- Currency
- BRL
What changed lately
Latest news release · Oct 1, 2026
Samsung Bioepis and Teva Expand Strategic Partnership to Advance Up to Six Potential Biosimilar Candidates
Latest earnings call · Jul 29, 2026
Teva Pharmaceutical Industries (TASE:TEVA) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Oct 9, 2026
Corporate Update (October 2026)
Corporate update · 15 slides
Calls
Upcoming
Teva Pharmaceutical Industries (TASE:TEVA) Q3 2026 Earnings Call
Tue, Nov 03, 2026 · 8:00 AM ET
Register
Replays
Teva Pharmaceutical Industries (TASE:TEVA) Q2 2026 Earnings Call
Wed, Jul 29, 2026 · 8:00 AM ET
Watch TranscriptTeva Pharmaceutical Industries (TASE:TEVA) Q1 2026 Earnings Call
Wed, Apr 29, 2026 · 8:00 AM ET
Watch TranscriptTeva Pharmaceutical Industries (TASE:TEVA) Q4 2025 Earnings Call
Wed, Jan 28, 2026 · 8:00 AM ET
Watch Transcript
Latest news
Financings
Senior notes
Sep 10, 2026
Announced: about US$4.9B
Use of proceeds: Redeem certain existing notes, pay related fees and expenses, and general corporate purposes including repaying outstanding debt
Decks
Corporate Update (October 2026)
Corporate update · 15 slides · Oct 9, 2026
IL-15 Celiac Disease Phase 2a Topline Results - Conference Call (September 2026)
Conference · 23 slides · Sep 2, 2026
Q2 2026 Earnings Presentation
Earnings · 74 slides · Jul 29, 2026
Technical Presentation (July 2026)
Technical · 18 slides · Jul 7, 2026
Teva Pharmaceutical Industries Limited on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 54 in the last 12 months · 100 in all · newest Oct 1, 2026 · oldest 2025
- Calls
- 14 calls with a replay · 14 with a transcript · latest Jul 29, 2026
- Decks
- 132 decks · latest Oct 9, 2026
Where Teva Pharmaceutical Industries Limited is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| TASE:TEVA · Home listing | TASE | Israel | ILA |
| NYSE:TEVA | NYSE | United States | USD |
| gettex:TEV | gettex | Germany | EUR |
| Frankfurt:TEV | Frankfurt | Germany | EUR |
| Tradegate:TEV | Tradegate | Germany | EUR |
| BOATS:TEVA | BOATS | United States | USD |
| OTC:TEVJF | OTC | United States | USD |
| LS Exchange:883035 | LS Exchange | Germany | EUR |
| B3:T1EV34 · This page | B3 | Brazil | BRL |
| BMV:TEVAN | BMV | Mexico | MXN |
| VIE:TEVA | Vienna | Austria | EUR |
| BX Swiss:TEV | BX Swiss | Switzerland | CHF |
| LSIN:0LER | LSIN | United Kingdom | USD |
| Stuttgart:TEV | Stuttgart | Germany | EUR |
| Hanover:TEV | Hanover | Germany | EUR |
| Lang & Schwarz:883035 | Lang & Schwarz | Germany | EUR |
| BSESOF:TEV | BSESOF | Bulgaria | EUR |
| Dusseldorf:TEV | Dusseldorf | Germany | EUR |
| Hamburg:TEV | Hamburg | Germany | EUR |
| Munich:TEV | Munich | Germany | EUR |
Log in to ask 6ix AI your own questions about Teva Pharmaceutical Industries Limited.